Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2024-04-19 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
独立董事2023年度述职报告（曹传德）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2023, detailing attendance at board meetings, independent opinions on board matters, on-site inspections, investor protection activities, committee work, and training. It is a narrative report on the director's duties and activities rather than a financial report or regulatory filing. It does not contain financial statements or earnings data, nor is it an announcement or proxy material. This fits best under Board/Management Information (MANG), which covers announcements related to board members and their activities.
2024-04-19 Chinese
关于获得创新药HSK16149胶囊新适应症《药物临床试验批准通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a pharmaceutical company about receiving a clinical trial approval notice for a new drug indication. It is a regulatory announcement about a specific event (approval of clinical trial application) rather than a financial report, management change, or other types of filings. The document is short (1433 characters) and focuses on regulatory approval information. It does not contain financial data, earnings, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-17 Chinese
关于获得创新药HSK31858片新适应症《药物临床试验批准通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a pharmaceutical company about receiving a clinical trial approval notice for a new drug indication. It includes details about the drug, regulatory approval, and risk warnings. The document is short (1115 characters) and does not contain financial data, earnings, or management discussion. It is an official announcement of a regulatory approval event rather than a financial report or detailed management information. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-04-11 Chinese
关于获得创新药HSK31858片新适应症《药物临床试验批准通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a pharmaceutical company about receiving approval from the National Medical Products Administration (国家药品监督管理局) for clinical trial authorization of a new drug indication. It details the drug name, clinical trial approval, and related regulatory information. The document is short (1469 characters) and primarily serves as an official announcement of regulatory approval rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-04-09 Chinese
关于获得产业发展扶持资金的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1265 characters) from a company about receiving industrial development support funds. It details the amount, timing, and accounting treatment of government subsidies related to ordinary business activities. There is no financial statement or comprehensive report included, nor is there a mention of an attached or published report. The content is a regulatory announcement about a specific financial event (receipt of government subsidies) rather than a full financial report or earnings release. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a regulatory announcement about a material event affecting the company’s financials, best classified under Regulatory Filings (RNS).
2024-03-31 Chinese
关于获得创新药HSK16149胶囊新适应症《药物临床试验批准通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement from 海思科医药集团股份有限公司 regarding the receipt of a clinical trial approval notice for a new drug indication. It details the drug, its intended use, and regulatory approval status. The document is short (1713 characters) and serves as an official announcement of regulatory approval rather than a detailed report or financial statement. There is no financial data, no management discussion, no earnings information, or other report content. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about clinical trial approval and does not fit other specific categories.
2024-03-31 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.